Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-17

Clinical Trial Update: Actinium Therapy for Late-stage Aggressive Sarcomas [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for Actinium Therapy in late-stage soft tissue sarcoma. The study is currently recruiting and sponsored by Ratio Therapeutics, Inc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Actinium Therapy

Snippet

Sponsor: Ratio Therapeutics, Inc. | Conditions: Advanced Soft Tissue Sarcoma | Phase 1 | Status: RECRUITING